According to online reports, Prenetics, a Nasdaq-listed company, announced that it would transfer its ownership of ACT Genomics Holdings Company Limited to Delta Electronics Co., Ltd. for US$71.78 million, bringing the company's cash reserves to approximately US$86 million and expected cash and short-term assets to US$117 million. The company maintains a debt-free balance sheet with zero debt, allowing it to explore other financial management options, including digital asset adoption and Bitcoin financial strategies. The company has completed the purchase of 187.42 bitcoins through its Kraken escrow account at an average price of $106,712.